4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-020709
Director sold 8,687 shares at an average $10.10 ($87,777)
From the SEC's structured data for this filing
Trades in this filing
Canaan IX L.P. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-05-19 | Sale : show line 1 in the form | −2,500 | $10.14 | $25,350 | 4,582,255 | I |
| 2016-05-20 | Sale : show line 2 in the form | −6,187 | $10.09 | $62,427 | 4,576,068 | I |
| Open-market sales · 8,687 sh · avg $10.10 · $87,777 | ||||||
Loading xslF345X03/doc4.xml…